We are live on ! Find out more
MCM

Martin Capital Management Portfolio holdings

AUM $36.5M
1-Year Est. Return 4.02%
This Fund
S&P 500
This Quarter Est. Return
+6.56%
1 Year Est. Return
-4.02%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$41.7M
AUM Growth
-$3.2M
Cap. Flow
-$6.04M
Cap. Flow %
-14.5%
Top 10 Hldgs %
95.46%
Holding
13
New
Increased
Reduced
11
Closed
1

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$2.97M
2
ABBV icon
AbbVie
ABBV
+$1.81M
3
GNTX icon
Gentex
GNTX
+$254K
4
T icon
AT&T
T
+$204K
5
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$200K

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 29.89%
2 Healthcare 28.74%
3 Financials 25.54%
4 Consumer Staples 10.22%
5 Technology 4.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GNTX icon
1
Gentex
GNTX
$4.97B
$10M 24.11%
784,878
-21,400
-3% -$254K
BRK.B icon
2
Berkshire Hathaway Class B
BRK.B
$1.1T
$6.45M 15.48%
56,816
-1,735
-3% -$200K
WMT icon
3
Walmart Inc
WMT
$885B
$4.26M 10.22%
172,617
-4,905
-3% -$124K
TRV icon
4
Travelers Companies
TRV
$78.1B
$4.19M 10.06%
49,427
-1,480
-3% -$122K
SYK icon
5
Stryker
SYK
$125B
$3.56M 8.53%
52,596
-1,755
-3% -$121K
AMGN icon
6
Amgen
AMGN
$208B
$2.69M 6.45%
23,993
-27,390
-53% -$2.97M
ABT icon
7
Abbott
ABT
$183B
$2.58M 6.18%
77,617
-2,305
-3% -$80.9K
THRM icon
8
Gentherm
THRM
$1.25B
$2.41M 5.78%
126,085
-2,935
-2% -$54.8K
GRMN
9
Garmin
GRMN
$56.7B
$1.85M 4.45%
41,056
-1,250
-3% -$49.7K
ABBV icon
10
AbbVie
ABBV
$443B
$1.75M 4.19%
39,040
-40,882
-51% -$1.81M
ENOV icon
11
Enovis
ENOV
$1.68B
$1.41M 3.39%
14,502
-513
-3% -$47.3K
EMMS
12
DELISTED
Emmis Communications Corp
EMMS
$481K 1.15%
47,561
T icon
13
AT&T
T
$159B
-7,613
Closed -$204K

Similar funds

Martin Capital Management's Q3 2013 Portfolio in Review

As of Q3 2013, Martin Capital Management held 13 positions worth $41.7M, down 7.1% from $44.9M the previous quarter. Its ten largest holdings account for 95% of the portfolio.

Martin Capital Management withdrew a net $6.04M in Q3 2013, closing 1 position and reducing 11 holdings. Its most notable exit was AT&T, an estimated $204K position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 30% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.

  • Martin Capital Management's biggest Q3 2013 reduction was Amgen, cutting an estimated $2.97M.
  • Martin Capital Management fully exited AT&T in Q3 2013, selling an estimated $204K.
  • Martin Capital Management's ten largest holdings make up 95% of its $41.7M portfolio in Q3 2013.
  • Martin Capital Management opened 0 new positions and closed 1 in Q3 2013.
  • Martin Capital Management's portfolio value fell 7.1% quarter-over-quarter to $41.7M.

Based on Martin Capital Management's 13F filing for Q3 2013, filed 5 Nov 2013.